Rationale for a study adding tamoxifen to HRT

Eur J Cancer. 2002 Nov:38 Suppl 6:S22-3. doi: 10.1016/s0959-8049(02)00272-1.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents, Hormonal / administration & dosage*
  • Breast Neoplasms / prevention & control*
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Hormone Replacement Therapy / methods*
  • Humans
  • Middle Aged
  • Randomized Controlled Trials as Topic
  • Selective Estrogen Receptor Modulators / administration & dosage*
  • Tamoxifen / administration & dosage*

Substances

  • Antineoplastic Agents, Hormonal
  • Selective Estrogen Receptor Modulators
  • Tamoxifen